Eugenol may have an apoptotic effect by reducing cyclooxygenase-2 (COX-2), B-cell lymphoma, and interleukin-1 beta production, and by increasing the activity of caspase-3 and caspase-9 caspase proteins. The gene discussed is PTGS2; the disease is B-cell non-Hodgkin lymphoma.